MannKind
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MannKind and other ETFs, options, and stocks.About MNKD
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501.
MNKD Key Statistics
Stock Snapshot
The current MannKind(MNKD) stock price is $3.74, with a market capitalization of 1.21B. The stock trades at a price-to-earnings (P/E) ratio of -26.46.
On 2026-09-15, MannKind(MNKD) stock moved within a range of $3.74 to $3.75. With shares now at $3.74, the stock is trading 0.0% above its intraday low and -0.3% below the session's peak.
Trading volume for MannKind(MNKD) stock has reached 659, versus its average volume of 3.17M.
Over the past 52 weeks, MannKind(MNKD) stock has traded between a high of $6.51 and a low of $2.23.
Over the past 52 weeks, MannKind(MNKD) stock has traded between a high of $6.51 and a low of $2.23.
MNKD News
...
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. If you have an ad-blocker enabled you may be blocked from pr...
MannKind (MNKD) and Rose Pharma announced that they have entered into a worldwide licensing and collaboration agreement to develop ROSE-010 Technosphere for wei...
Analyst ratings
88%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.